Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein

Journal of General Virology

Volumn 78, Issue 8, 1997, Pages 1999-2007

  Kropff, Barbara ^a   Mach, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; EPITOPE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; GENE ISOLATION; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; IMMUNOSURVEILLANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; VIRION;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 8; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030765624     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-8-1999     Document Type: Article

References (31)

1. Adler, S. P., Starr, S. E., Plotkin, S. A., Hempfling, S. H., Buis, J., Manning, M. L. & Best, A. M. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. Journal of Infectious Diseases 171, 26-32.
2. Alford, C. A., Stagno, S., Pass, R. F. & Britt, W. J. (1990). Congenital and perinatal cytomegalovirus infections. Reviews of Infectious Diseases 12(Suppl. 7), S745-S753.
3. Almeida, J., Lang, D. & Talbot, P. (1978). Herpesvirus morphology: visualization of a structural subunit. Intervirology 10, 318-320.
4. Basgoz, N., Qadri, I., Navarro, D., Sears, A., Lennette, E., Youngblom, J. & Pereira, L. (1992). The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. Journal of General Virology 73, 983-988.
5. Baskin, G. B. (1987). Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. American Journal of Pathology 129, 345-352.
6. Britt, W. J. & Vugler, L. G. (1992). Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). Journal of Virology 66, 6747-6754.
7. Britt, W. J., Vugler, L., Butfiloski, E. J. & Stephens, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64, 1079-1085.
8. Davis, M. G., Kenney, S. C., Kamine, J., Pagano, J. S. & Huang, E. S. (1987). Immediate-early gene region of human cytomegalovirus transactivates the promoter of human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 84, 8642-8646.
9. Ehrlich, P. H., Moustafa, Z. A., Justice, J. C., Harfeldt, K. E. & Ostberg, L. (1988). Further characterization of the fate of human monoclonal antibodies in rhesus monkeys. Hybridoma 7, 385-395.
10. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. & Alford, C. A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New England Journal of Medicine 326, 663-667.
11. Harlow, E. & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
12. Ho, M. (1991). Cytomegalovirus Biology & Infection, 2nd edn. New York: Plenum.
13. Jacobson, M. A. & Mills, J. (1988). Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Annals of Internal Medicine 108, 585-594.
14. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P. & Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179, 1713-1717.
15. Kaur, A., Daniel, M. D., Hempel, D., Lee-Parritz, D., Hirsch, M. S. & Johnson, P. R. (1996). Cytotoxic T-lymphocyte response to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. Journal of Virology 70, 7725-7733.
16. Kniess, N., Mach, M., Fay, J. & Britt, W. J. (1991). Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. Journal of Virology 65, 138-146.
17. Marshall, G. S., Rabalais, G. P., Stout, G. G. & Waldeyer, S. L. (1992). Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. Journal of Infectious Diseases 165, 381-384.
18. Marshall, G. S., Stout, G. G., Knights, M. E., Rabalais, G. P., Ashley, R., Miller, H. & Rossier, E. (1994). Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection. Journal of Medical Virology 43, 77-83.
19. Meyer, H., Masuho, Y. & Mach, M. (1990). The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. Journal of General Virology 71, 2443-2450.
20. Meyer, H., Sundqvist, V. A., Pereira, L. & Mach, M. (1992). Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73, 2375-2383.
21. Nelson, J. A., Reynolds-Kohler, C., Oldstone, M. B. & Wiley, C. A. (1988). HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165, 286-290.
22. Ohlin, M., Sundqvist, V. A., Mach, M., Wahren, B. & Borrebaeck, C. A. (1993). Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. Journal of Virology 67, 703-710.
23. Rapp, M., Messerle, M., Buhler, B., Tannheimer, M., Keil, G. M. & Koszinowski, U. H. (1992). Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. Journal of Virology 66, 4399-4406.
24. Reddehase, M. J., Mutter, W., Munch, K., Buhring, H. J. & Koszinowski, U. H. (1987). CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. Journal of Virology 61, 3102-3108.
25. Reschke, M., Reis, B., Noding, K., Rohsiepe, D., Richter, A., Mockenhaupt, T., Garten, W. & Radsak, K. (1995). Constitutive expression of human cytomegalovirus glycoprotein B (gpUL55) with mutagenized carboxy-terminal hydrophobic domains. Journal of General Virology 76, 113-122.
26. Reusser, P., Riddell, S. R., Meyers, J. D. & Greenberg, P. O. (1991). Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78, 1373-1380.
27. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
28. Schoppel, K., Hassfurther, E., Britt, W. J., Ohlin, M., Borrebaeck, C. A. & Mach, M. (1996). Antibodies specific for the antigenic domain 1 (AD-1) of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures. Virology 216, 133-145.
29. Skolnik, P. R., Kosloff, B. R. & Hirsch, M. S. (1988). Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. Journal of Infectious Diseases 157, 508-514.
30. Vey, M., Schafer, W., Reis, B., Ohuchi, R., Britt, W., Garten, W., Klenk, H. D. & Radsak, K. (1995). Proteolytic processing of human cytomegalovirus glycoprotein B (gpULSS) is mediated by the human endoprotease furin. Virology 206, 746-749.
31. Wagner, B., Kropff, B., Kalbacher, H., Britt, W., Sundqvist, V. A., Ostberg, L. & Mach, M. (1992). A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. Journal of Virology 66, 5290-5297.